BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7676619)

  • 1. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.
    Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE
    Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
    Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
    Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethality of PE2 incorporation into Sindbis virus can be suppressed by second-site mutations in E3 and E2.
    Heidner HW; McKnight KL; Davis NL; Johnston RE
    J Virol; 1994 Apr; 68(4):2683-92. PubMed ID: 7908062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages.
    Grieder FB; Nguyen HT
    Microb Pathog; 1996 Aug; 21(2):85-95. PubMed ID: 8844652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of site-directed mutations of transmembrane cysteines in sindbis virus E1 and E2 glycoproteins on palmitylation and virus replication.
    Ryan C; Ivanova L; Schlesinger MJ
    Virology; 1998 Sep; 249(1):62-7. PubMed ID: 9740777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
    Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
    Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis.
    Davis NL; Grieder FB; Smith JF; Greenwald GF; Valenski ML; Sellon DC; Charles PC; Johnston RE
    Arch Virol Suppl; 1994; 9():99-109. PubMed ID: 8032286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.
    Davis NL; Powell N; Greenwald GF; Willis LV; Johnson BJ; Smith JF; Johnston RE
    Virology; 1991 Jul; 183(1):20-31. PubMed ID: 2053280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the endo domain of Sindbis virus glycoprotein E2 block phosphorylation, reorientation of the endo domain, and nucleocapsid binding.
    Liu LN; Lee H; Hernandez R; Brown DT
    Virology; 1996 Aug; 222(1):236-46. PubMed ID: 8806503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.